Original Research Article
Neural Correlates of the Clock Drawing Test Performance in Alzheimer’s Disease: A FDG-PET StudyLee D.Y.a, d · Seo E.H.d · Choo I.H.a · Kim S.G.e · Lee J.S.b · Lee D.S.b · Jhoo J.H.f · Kim K.W.g · Youn J.C.h · Woo J.I.a, c, d
aDepartment of Neuropsychiatry and Clinical Research Institute, and bDepartment of Nuclear Medicine, Seoul National University Hospital, and cNeuroscience Research Institute, Medical Research Center and dInterdisciplinary Program in Cognitive Science, Seoul National University, Seoul, Departments of Psychiatry, eSoon Chun Hyang University Hospital, Bucheon, and fKangwon National University Hospital, Chuncheon, and Departments of Neuropsychiatry, gSeoul National University Bundang Hospital, Seongnam, and hKyunggi Provincial Hospital for the Elderly, Yongin, Korea
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background/Aim: This study aimed to identify the functional neuroanatomical correlates of impaired clock drawing test (CDT) performance in patients with Alzheimer’s disease (AD). Method: The CDT was administered to 71 patients with AD, and regional cerebral glucose metabolism (rCMglc) was measured by positron emission tomography (PET). Correlations between CDT scores and rCMglc were examined on a voxel-by-voxel basis. Results: Significant positive correlations were found between CDT performance and rCMglc in the right inferior parietal lobule and right posterior cingulate cortex. Conclusion: These results provide the first PET evidence that poor CDT performance in patients with AD is closely related to the functional decline in the right hemisphere, especially the right parietal cortex.
© 2008 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.